%20(Blog%20Banner).png)
HealthEdge Investment Partners has successfully closed its fourth fund, surpassing its target with over $160 million in commitments from existing and new investors in the healthcare industry.
The private equity firm focuses on lower middle market healthcare companies, providing institutional capital and operational expertise to drive transformation, growth, and cultural excellence.
With a strong track record of acquisitions and exits, HealthEdge has allocated a portion of Fund IV to two platform investments, Anodyne and Veridian Healthcare, in the diabetic footwear solutions and in-home diagnostic products sectors respectively.
